-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Erratum
(2218) Views (370) Full article downloads
Authors:
Published Date May 2006
Volume 2006:2(4) Pages 515 - 515
DOI: http://dx.doi.org/10.2147/VHRM.S
Asmar R, Nisse-Durgeat S. 2006. A large scale study of angiotensin II inhibition therapy in an elderly population. Vasc Health Risk Manag, 2:317-23.
On p 320, left column, the last sentence of the first paragraph should read:
“Comparable results were observed in the PP population: the target was achieved by 63.8% and 85.6% at week 4 and week 8, respectively.”
Readers of this article also read:
Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
The impact of health literacy on cardiovascular disease
Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum
A case of recurrent bloody tears
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
